Related Experiment Video
Updated: May 24, 2026

Transcatheter Pulmonary Valve Replacement from Autologous Pericardium with a Self-Expandable Nitinol Stent in an Adult Sheep Model
Published on: June 8, 2022
Tricuspid transcatheter valve-in-valve: an alternative for high-risk patients
Diego Felipe Gaia1, José Honório Palma, José Augusto Marcondes de Souza
1Department of Cardiovascular Surgery, Federal University of São Paulo, São Paulo, Brazil. drgaia@terra.com.br
Abstract:
Tricuspid valve disease is not uncommon. Some patients with tricuspid valve disease require tricuspid replacement with bioprosthesis and, over time, may require re-interventions. Transcatheter tricuspid valve-in-valve approach has emerged as an alternative to treat dysfunctional bioprosthesis. In this article, we report a case of a patient with four previous cardiac interventions presenting with tricuspid bioprosthesis dysfunction. The patient was treated with the transcatheter transatrial tricuspid valve-in-valve procedure. The procedure was successful with no residual leakage and a non-significant mean gradient. The patient recovered well and was discharged in 1 week. The procedure is a feasible alternative for high-risk patients. Selection and postoperative care are crucial for the outcome.
Related Concept Videos
Mitral Stenosis III: Medical Management
Mitral Regurgitation III: Medical Management
Venous Thrombosis III: Interprofessional Care
Aortic Regurgitation III: Medical Management
Mitral Valve Prolapse II: Assessment and Management